Dilip Buildcon IPO is going to hit capital markets on August 1.
Dilip Buildcon IPO is going to hit capital markets on August 1. The public offer comprises of fresh issue of equity shares aggregating up to Rs 430 crore and an offer for sale of up to 1,136,364 equity shares by Dilip Suryavanshi, up to 1,136,364 equity shares by Devendra Jain and up to 7,954,545 equity shares by the BanyanTree Growth Capital, LLC. The issue will close on August 3. The company has fixed price band of Rs 214–219 per equity share of face value of Rs 10 each for the public offer.
Bhopal-based private sector road-focus EPC contractor will use the net proceed of the fresh issue for prepayment or repayment of a portion of term loans availed by the company, to meet working capital requirements and general corporate purposes. Dilip Buildcon will not receive any proceeds from the offer for sale. Anchor investor can bid on July 29, one working day prior to the issue opening date. Shares of the company are proposed to be listed on the NSE and BSE.
IIFL Holdings, JM Financial, Axis Capital Limited and PNB Investment Services are the book running lead managers to the issue. The company has grown from Rs 1,192 crore in FY2012 to Rs 4,349 crore in FY2016.
According to IIFL, Dilip Buildcon order book multiplied 4 times owing to strong business development activities in the past five financial years. The higher order book has been followed by strong execution with standalone revenue and EBITDA recording a CAGR of 57 per cent and 55 per cent respectively during FY11-16 period. As per CRISIL Research, road investments are likely to be receiving an impetus during FY16-20 period.
Of late, IPOs of Advanced Enzyme got robust response from investors as it was oversubscribed by 116.91 times.